Abstract
With the advances in preoperative localization studies and greater demand for less-invasive procedures, novel targeted approaches to the parathyroid glands have been described and practiced over the past two decades. Despite the various surgical options, no single technique has been established as superior to another. The da Vinci Si Surgical Robot System is considered to be the latest addition to the endocrine surgeon’s armamentarium to accomplish remote-access, targeted parathyroidectomy. Its application in head and neck surgery has gained wide popularity in Asia and recently in European and North American practice. Robotic parathyroidectomy overcomes the limitations of conventional endoscopic surgery while avoiding a cervical scar by concealing it in the axilla, infraclavicular area, or the retroauricular area. The evidence from the present review shows that robotic parathyroidectomy is equivalent to conventional, targeted parathyroidectomy with regards to cure and complication rates. As with every surgical technique, appropriate patient selection is crucial. Long-term data are currently awaited on robotic parathyroidectomy especially in view of its high cost and long operative time compared to targeted parathyroidectomy and other minimally invasive techniques. At present, robotic parathyroidectomy can only be justified in patients who are predisposed to keloid or hypertrophic scarring or have cultural considerations leading to the desire to avoid a neck scar.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Palazzo FF, Delbridge LW. Minimal-access/minimally invasive parathyroidectomy for primary hyperparathyroidism. Surg Clin North Am. 2004;84:717–34. Clinical Review—EBM level 5.
Tibblin S, Bondeson AG, Bondeson L, Ljungberg O. Surgical strategy in hyperparathyroidism due to solitary adenoma. Ann Surg. 1984;200(6):776–84. Population/Observational Study—EBM level 3-A.
Gagner M. Endoscopic subtotal parathyroidectomy in patients with primary hyperparathyroidism. Br J Surg. 1996;83(6):875. Population/Observational Study—EBM level 4.
Miccoli P, Bendinelli C, Berti P, Vignali E, Pinchera A, Marcocci C. Video-assisted versus conventional parathyroidectomy in primary hyperparathyroidism: a prospective randomized study. Surgery. 1999;126:1117–21. discussion 21–2, Population/Observational Study—EBM level 2-A.
Costello D, Norman J. Minimally invasive radioguided parathyroidectomy. Surg Oncol Clin N Am. 1999;8(3):555–64. Clinical Review—EBM level 5.
Ikeda Y, Takami H. Endoscopic parathyroidectomy. Biomed Pharmacother. 2000;54 Suppl 1:52s–6. Population/Observational Study—EBM level 4.
Tolley N, Arora A, Palazzo F, Garas G, Dhawan R, Cox J, et al. Robotic-assisted parathyroidectomy: a feasibility study. Otolaryngol Head Neck Surg. 2011;144:859–66. Population/Observational Study—EBM level 3-A.
Katz L, Abdel Khalek M, Crawford B, Kandil E. Robotic-assisted transaxillary parathyroidectomy of an atypical adenoma. Minim Invasive Ther Allied Technol. 2011;21(3):201–5. Population/Observational Study—EBM level 4.
Landry CS, Grubbs EG, Morris GS, Turner NS, Holsinger FC, Lee JE, et al. Robot assisted transaxillary surgery (RATS) for the removal of thyroid and parathyroid glands. Surgery. 2011;149:549–55. Population/Observational Study—EBM level 3-A.
Foley CS, Agcaoglu O, Siperstein AE, Berber E. Robotic transaxillary endocrine surgery: a comparison with conventional open technique. Surg Endosc Clin Investig. 2012;26(8):2259–66. EBM level 2-A.
Noureldine SI, Lewing N, Tufano RP, Kandil E. The role of the robotic-assisted transaxillary gasless approach for the removal of parathyroid adenomas. ORL J Otorhinolaryngol Relat Spec. 2014;76(1):19–24. Population/Observational Study—EBM level 4.
Kang SW, Lee SC, Lee SH, Lee KY, Jeong JJ, Lee YS, et al. Robotic thyroid surgery using a gasless, transaxillary approach and the da Vinci S system: the operative outcomes of 338 consecutive patients. Surgery. 2009;146:1048–55. Population/Observational Study— EBM level 3-A.
Holsinger FC, Terris DJ, Kuppersmith RB. Robotic thyroidectomy: operative technique using a transaxillary endoscopic approach without CO2 insufflation. Otolaryngol Clin North Am. 2010;43:381–8. ix-x, Elsevier Inc., Clinical Review—EBM level 5.
Lee J, Nah KY, Kim RM, Ahn YH, Soh EY, Chung WY. Differences in postoperative outcomes, function, and cosmesis: open versus robotic thyroidectomy. Surg Endosc. 2010;24(12):3186–94. Clinical Investigation—EBM level 2-A.
Landry CS, Grubbs EG, Warneke CL, Ormond M, Chua C, Lee JE, et al. Robot-assisted transaxillary thyroid surgery in the United States: is it comparable to open thyroid lobectomy? Ann Surg Oncol. 2012;19(4):1269–74. Clinical Investigation—EBM level 2-A.
Perrier ND. Why I, have abandoned robot-assisted transaxillary thyroid surgery. Surgery. 2012;152(6):1025–6. Clinical Review EBM level 5.
Kuppersmith RB, Holsinger FC. Robotic thyroid surgery: an initial experience with North American patients. Laryngoscope. 2011;121(3):521–6. Population/Observational Study—EBM level 3-A.
Dionigi G. Robotic thyroidectomy: Seoul is not Varese. Otolaryngol Head Neck Surg. 2013;148:178. Clinical Review—EBM level 5.
Terris DJ, Singer MC, Seybt MW. Robotic facelift thyroidectomy: II. Clinical feasibility and safety. Laryngoscope. 2011;121(8):1636–41. Population/Observational Study—EBM level 3-A.
Lee JM, Byeon HK, Choi EC, Koh YW. Robotic excision of a huge parathyroid adenoma via a retroauricular approach. J Craniofac Surg. 2015;26(1):e55–8. Popilation/Observational Study—EBM level 4.
Karagkounis G, Uzun DD, Mason DP, Murthy SC, Berber E. Robotic surgery for primary hyperparathyroidism. Surg Endosc. 2014;28(9):2702–7. Population/Observational Study—EBM level 4.
Tolley N, Garas G, Palazzo F, Prichard A, Chaidas K, Cox J, et al. A long-term prospective evaluation comparing robotic parathyroidectomy with minimally invasive open parathyroidectomy for primary hyperparathyroidism. Head Neck. 2014. doi:10.1002/hed.23990. Clinical Investigation—EBM level 2-A.
Irvin 3rd GL, Molinari AS, Figueroa C, Carneiro DM. Improved success rate in reoperative parathyroidectomy with intraoperative PTH assay. Ann Surg. 1999;229(6):874–8. discussion 8-9, Population/Observational Study—EBM level 3-A.
Mazzeo S, Caramella D, Lencioni R, Molea N, De Liperi A, Marcocci C, et al. Comparison among sonography, double-tracer subtraction scintigraphy, and double-phase scintigraphy in the detection of parathyroid lesions. AJR Am J Roentgenol. 1996;166(6):1465–70. Population/Observational Study—EBM level 3-B.
Lee JA, Inabnet 3rd WB. The surgeon’s armamentarium to the surgical treatment of primary hyperparathyroidism. J Surg Oncol. 2005;89(3):130–5. Clinical Review—EBM level 5.
Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C, et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab. 2001;86(12):5658–71. Clinical Review—EBM level 5.
Bilezikian JP, Khan AA, Potts Jr JT. Third International Workshop on the Management of Asymptomatic Primary H. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab. 2009;94(2):335–9. Clinical Review—EBM level 5.
Ruda JM, Hollenbeak CS, Stack Jr BC. A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol Head Neck Surg. 2005;132(3):359–72. Clinical Investigation—EBM level 2-C.
Rodgers SE, Hunter GJ, Hamberg LM, Schellingerhout D, Doherty DB, Ayers GD, et al. Improved preoperative planning for directed parathyroidectomy with 4-dimensional computed tomography. Surgery. 2006;140(6):932–40. discussion 40-1, Population/Observational Study—EBM level 3-A.
Chen H, Pruhs Z, Starling JR, Mack E. Intraoperative parathyroid hormone testing improves cure rates in patients undergoing minimally invasive parathyroidectomy. Surgery. 2005;138(4):583–7. discussion 7-90, Clinical Investigation—EBM level 2-A.
Carneiro DM, Solorzano CC, Nader MC, Ramirez M, Irvin 3rd GL. Comparison of intraoperative iPTH assay (QPTH) criteria in guiding parathyroidectomy: which criterion is the most accurate? Surgery. 2003;134(6):973–9. discussion 9-81, Population/Observational Study—EBM level 3-B.
Chiu B, Sturgeon C, Angelos P. Which intraoperative parathyroid hormone assay criterion best predicts operative success? A study of 352 consecutive patients. Arch Surg. 2006;141(5):483–7. discussion 7-8, Population/Observational Study—EBM level 3-A.
Irvin 3rd GL, Solorzano CC, Carneiro DM. Quick intraoperative parathyroid hormone assay: surgical adjunct to allow limited parathyroidectomy, improve success rate, and predict outcome. World J Surg. 2004;28(12):1287–92. Population/Observational Study—EBM level 3-A.
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Electronic Supplementary Material
Below is the link to the electronic supplementary material.
Robotic transaxillary parathyroidectomy of a left inferior parathyroid adenoma (M4V 184345 kb)
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Noureldine, S.I., Murad, F., Kandil, E., Tufano, R.P. (2017). Robotic Parathyroidectomy. In: Stack, Jr., B., Bodenner, D. (eds) Medical and Surgical Treatment of Parathyroid Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-26794-4_26
Download citation
DOI: https://doi.org/10.1007/978-3-319-26794-4_26
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-26792-0
Online ISBN: 978-3-319-26794-4
eBook Packages: MedicineMedicine (R0)